Veranova: A CDMO that manages complexity with confidence.
01 1Veranova, L.P.
02 1B&B Pharmaceuticals, Inc.
03 3Cambrex Charles City, Inc
04 1Chattem Chemicals, Inc.
05 1Curia Wisconsin, Inc.
06 1Fagron Inc
07 1LETCO MEDICAL, LLC
08 1Medisca Inc.
09 1Pharma Source Direct, Inc.
10 1Professional Compounding Centers of America dba PCCA
11 4SpecGx LLC
01 3FENTANYL CITRATE
02 13Fentanyl Citrate
01 4Ireland
02 1Netherlands
03 10U.S.A
04 1United Kingdom
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 49812-0001
Start Marketing Date : 1985-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-3280
Start Marketing Date : 2012-10-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-3281
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0687
Start Marketing Date : 1998-04-01
End Marketing Date : 2026-02-28
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0406-1130
Start Marketing Date : 1996-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1205
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1333
Start Marketing Date : 2013-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1344
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-1756
Start Marketing Date : 2012-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0042
Start Marketing Date : 2002-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Fentanyl Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fentanyl Citrate, including repackagers and relabelers. The FDA regulates Fentanyl Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fentanyl Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fentanyl Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fentanyl Citrate supplier is an individual or a company that provides Fentanyl Citrate active pharmaceutical ingredient (API) or Fentanyl Citrate finished formulations upon request. The Fentanyl Citrate suppliers may include Fentanyl Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Fentanyl Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fentanyl Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fentanyl Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fentanyl Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fentanyl Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fentanyl Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fentanyl Citrate suppliers with NDC on PharmaCompass.
We have 11 companies offering Fentanyl Citrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
